Related Experiment Video
Updated: Jul 11, 2025

Sucrose Preference and Novelty-Induced Hypophagia Tests in Rats using an Automated Food Intake Monitoring System
Published on: May 8, 2020
Savory Cracker Development for Blood Glucose Control and Management: Glycogen Storage Diseases
Xin Qi1, Minh N Ta1, Richard F Tester1
1Glycologic Limited, Reading, United Kingdom.
Savory slow energy-release crackers (GLY-HYP) demonstrated a stable blood glucose response in patients with glycogen storage diseases (GSDs) Types I and IV. These findings suggest GLY-HYP crackers could be a beneficial dietary option for individuals with GSDs.
Area of Science:
- Metabolic disorders
- Nutritional science
- Clinical nutrition
Background:
- Glycogen storage diseases (GSDs) are a group of inherited metabolic disorders affecting glucose metabolism.
- Managing blood glucose levels is crucial for individuals with GSDs to prevent hypoglycemia and other complications.
- Previous studies indicated that GLY-HYP crackers provide a slow, sustained glucose release in healthy individuals.
Purpose of the Study:
- To evaluate the blood glucose response to GLY-HYP crackers in patients with GSD Types I and IV.
- To determine the suitability of GLY-HYP crackers as a dietary component for GSD patients.
Main Methods:
- A clinical study involving adult volunteers diagnosed with GSD Types I and IV.
- Participants consumed GLY-HYP crackers, and their blood glucose levels were monitored over a 4-hour period.
- Analysis of blood glucose concentration trends, including peak levels and duration above baseline.
Main Results:
- In GSD Type I patients (ages 53-70), blood glucose peaked at 9.5 mmol/L at 60 min, remaining above baseline for 210 min and above 5 mmol/L for 4 hours.
- In GSD Type IV patients (ages 55-72), blood glucose peaked at 10.2 mmol/L at 45 min, remaining above baseline for 150 min and above 5 mmol/L for 4 hours.
- Both GSD groups exhibited a relatively flat blood glucose response, similar to healthy individuals.
Conclusions:
- GLY-HYP crackers demonstrate a favorable, sustained blood glucose response in individuals with GSD Types I and IV.
- These crackers represent a potentially valuable nutritional option for managing dietary needs in GSD patients across various age groups.
- Further research may explore the long-term impact and broader applicability of GLY-HYP crackers in GSD management.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
06:59Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Related Concept Videos
Hypoglycemia and Glucagon
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
Acarbose and miglitol are...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Glucose Absorption Into the Small Intestine